Replimune (REPL) Other Non-Current Assets (2018 - 2026)
Replimune (REPL) reported Other Non-Current Assets of $3.24 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 89.7% from $1.71 million a year earlier and up 10.1% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Other Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune posted Other Non-Current Assets of $2.94 million, up 72.8% from FY2025.
- Other Non-Current Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 12.5% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Assets came in at $1.7 million in FY2025 (+0.2%), $1.7 million in FY2024 (+3.9%), $1.64 million in FY2023 (unchanged) and $1.64 million in FY2022 (unchanged).
- The fiscal Q1 2027 figure ranks as the highest quarterly Other Non-Current Assets in data going back to fiscal Q4 2018.
- Year over year, Other Non-Current Assets has now increased in each of the last three quarters, with growth averaging 21.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Other Non-Current Assets ran from 0.0% in fiscal Q2 2022 to 89.7% in fiscal Q1 2027.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $2.94 million (Q4 2026), $1.7 million (Q3 2026) and $1.71 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 1.64 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.64 Mn |
API Access
Replimune Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();